HAEMONETICS CORPORATION (NYSE:HAE) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02
DEPARTURE OF DIRECTORS OR CERTAI OFFICERS; ELECTION OF DIRETORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS
On October 17, 2017, the Board of Directors of Haemonetics Corporation (the “Company”) elected Robert E. Abernathy to serve as a Class III Director for a term expiring at the 2020 Annual Meeting of Shareholders and appointed Mr. Abernathy to serve as a member of the Compensation Committee of the Board of Directors. Mr. Abernathy was formerly Chairman of the Board of Directors and Chief Executive Officer of Halyard Health, Inc.
As a non-employee director of the Company, Mr. Abernathy will receive compensation as described in the “Directors’ Compensation” section of the Company’s 2017 Proxy Statement. In connection with his election, Mr. Abernathy received a grant of 2,909 Restricted Stock Units representing a pro rata annual equity grant based on the number of days to be served from Mr. Abernathy’s election through the first anniversary of the 2017 Annual Meeting of Shareholders, on which date the Restricted Stock Unit award vests in full.
A copy of the Company’s press release announcing the election of Mr. Abernathy is filed with this Current Report on Form 8-K as Exhibit 99.1.
Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d)Exhibits
|
Exhibit Number |
Description |
|
99.1 |
Press Release dated October 18, 2017
|
HAEMONETICS CORP ExhibitEX-99.1 2 a10182017robertabernathypr.htm EXHIBIT 99.1 Exhibit News Release FOR RELEASE: CONTACT:Date October 18,…To view the full exhibit click here
About HAEMONETICS CORPORATION (NYSE:HAE)
Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company’s segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals. The Company enables plasma collection customers to source from it a range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers and intravenous solutions, such as saline. Haemonetics offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The Company offers a range of blood management solutions. The Company has a suite of integrated software solutions, which include solutions for blood drive planning and blood collection.
